<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ymj</journal-id><journal-title-group><journal-title xml:lang="ru">Якутский медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Yakut Medical Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1813-1905</issn><issn pub-type="epub">2312-1017</issn><publisher><publisher-name>ЯНЦ КМП</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.25789/YMJ.2024.85.02</article-id><article-id custom-type="elpub" pub-id-type="custom">ymj-297</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>Оценка взаимосвязей показателей липидного обмена и легочной гипертензии в начальные периоды инфаркта миокарда у мужчин моложе 60 лет</article-title><trans-title-group xml:lang="en"><trans-title>Assessment of the relationship of lipid metabolism and pulmonary hypertension in the initial periods of myocardial infarction in men under 60 years old</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Меньшикова</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Menshikova</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>МЕНЬШИКОВА Александра Николаевна – адъюнкт</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>MENSHIKOVA Alexandra Nikolaevna – adjunct of the Department of Hospital Therapy</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сотников</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Sotnikov</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>СОТНИКОВ Алексей Владимирович – д.м.н., доцент, проф.</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>SOTNIKOV Alexey Vladimirovich – Doctor of Medical Sciences, Docent, Professor of the Department of Hospital Therapy</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гордиенко</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Gordienko</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ГОРДИЕНКО Александр Волеславович – д.м.н., проф.</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>GORDIENKO Alexander Voleslavovich – Doctor of Medi- cal Sciences, Professor, Associate Professor of the Department of Hospital Therapy</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Носович</surname><given-names>Д. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Nosovich</surname><given-names>D. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>НОСОВИЧ Дмитрий Владимирович – к.м.н., ст. преподаватель</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>NOSOVICH Dmitry Vladimirovich – Candidate of Medical Sciences, Senior Lecturer at the Department of Hospital Therapy</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Военно-медицинская академия им. С.М. Кирова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>S.M. Kirov Military Medical Academy</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>06</day><month>02</month><year>2025</year></pub-date><volume>0</volume><issue>1</issue><fpage>8</fpage><lpage>12</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Меньшикова А.Н., Сотников А.В., Гордиенко А.В., Носович Д.В., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Меньшикова А.Н., Сотников А.В., Гордиенко А.В., Носович Д.В.</copyright-holder><copyright-holder xml:lang="en">Menshikova A.N., Sotnikov A.V., Gordienko A.V., Nosovich D.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://ymj.elpub.ru/jour/article/view/297">https://ymj.elpub.ru/jour/article/view/297</self-uri><abstract><p>Изучены параметры липидного обмена у мужчин с легочной гипертензией (ЛГ), развившейся на фоне инфаркта миокарда (ИМ), и их влияния на риск развития ЛГ. По уровню среднего давления в легочной артерии (СДЛА), определенном при эхокардиографии, пациентов разделили на две группы: исследуемую (с уровнем СДЛА более 20 мм рт.ст. в конце третьей недели ИМ) и группу сравнения (с нормальным уровнем СДЛА в конце третьей недели ИМ). Установлено, что у пациентов исследуемой группы более низкие уровни коэффициента атерогенности (КА) и индекса общий холестерин/липопротеиды высокой плотности (ОХ/ЛпВП). Уровни триглицеридов (ТГД) &lt; 1,3 ммоль/л и липопротеидов очень низкой плотности (ЛпОНП) ≥ 1,2 ммоль/л, значения индексов ОХ/ЛпВП &lt; 6,0 и ЛпНП/ЛпВП &lt; 3,2 в первые 48 ч, ЛпНП &lt; 2,4 ммоль/л, величина КА &lt; 5,0, индексов ОХ/ЛпВП &lt; 6,0 и ЛпНП/ЛпВП &lt; 3,2 в конце третьей недели ИМ оказывают влияние на риск развития ЛГ в подостром периоде ИМ. Также установлены корреляции между уровнем СДЛА и показателями липидограммы. Полученные результаты целесообразно использовать при разработке модели прогнозирования развития ЛГ на фоне ИМ. </p></abstract><trans-abstract xml:lang="en"><p>Pulmonary hypertension (PH) is an understudied but significant complication of myocardial infarction (MI). Currently, there are no diagnostic algorithms that can predict the development of PH in the setting of myocardial infarction, which requires the development of prediction models based on the results of routine examination, for example, lipid profile. The purpose of the research was to study the parameters of lipid metabolism in men with PH that developed against the background of MI and their impact on the risk of developing PH. The results of examination of men aged 32-60 years with verified MI were studied. According to the level of mean pulmonary artery pressure (MPAP) determined by echocardiography, patients were divided into two groups: the study group (with a MPAP level of more than 20 mm Hg at the end of the third week of MI) and the comparison group (with a normal MPAP level at the end of the third week of MI). The studied indicators were compared based on the Mann-Whitney, Wilcoxon, and Chi-square tests; correlations were performed using the Spearman method. It was found that patients in the study group had lower levels of the atherogenic coefficient (AC) and the total cholesterol/high-density lipoprotein (TC/HDL) index at the end of the third week of MI. Levels of triglycerides (TG) &lt; 1.3 mmol/l and very low density lipoprotein (VLDL) ≥ 1.2 mmol/l, TC/HDL indices &lt; 6.0 and LDL/HDL &lt; 3.2 in the first 48 hours, LDL &lt;2.4 mmol/l, AC value &lt;5.0, TC/HDL indices &lt;6.0 and LDL/HDL &lt;3.2 at the end of the third week of MI influence the risk of developing PH in the subacute period of MI. Correlations have also been established between the level of MPAP and lipid profile parameters. It is advisable to use the obtained results when developing a model for predicting the development of PH against the background of MI. </p></trans-abstract><kwd-group xml:lang="ru"><kwd>легочная гипертензия</kwd><kwd>инфаркт миокарда</kwd><kwd>метаболизм липидов</kwd><kwd>среднее давление в легочной артерии</kwd><kwd>сердечная недостаточность</kwd><kwd>мужчины</kwd><kwd>молодой и средний возраст</kwd></kwd-group><kwd-group xml:lang="en"><kwd>pulmonary hypertension</kwd><kwd>myocardial infarction</kwd><kwd>lipid metabolism</kwd><kwd>mean pulmonary artery pressure</kwd><kwd>heart failure</kwd><kwd>men</kwd><kwd>young and middle age</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Легочная гипертензия, в том числе хроническая тромбоэмболическая легочная гипертензия. Клинические рекомендации 2020 / С.Н. Авдеев [и др.] // Российский кардиологический журнал. 2021. № 12. С. 198-267. doi:10.15829/1560-4071-2021-4683.</mixed-citation><mixed-citation xml:lang="en">Avdeev S.N. [et al.] Legochnaya gipertenziya, v tom chisle khronicheskaya tromboembolicheskaya legochnaya gipertenziya. Klinicheskie rekomendatsii 2020 [Pulmonary hypertension, including chronic thromboembolic pulmonary hypertension. Clinical guidelines 2020]. Rossiyskiy kardiologicheskiy zhurnal [Russian Journal of Cardiology. 2021; 12:198-267 (In Russ.).] doi:10.15829/1560-4071-2021-4683.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Pulmonary hypertension, including chronic thromboembolic pulmonary hypertension. Clinical guidelines 2020 / S.N. Avdeev [et al.] // Russian Journal of Cardiology. 2021. V. 12. P. 198-267. doi:10.15829/1560-4071-2021-4683.</mixed-citation><mixed-citation xml:lang="en">Litovskiy I.A., Gordienko A.V., Sotnikov A.V. Dostatochno li obosnovany tseli, k kotorym my stremimsya? [Are the goals we strive for sufficiently justified?] Klinicheskaya farmakologiya i terapiya. [Clinical pharmacology and therapy. 2019; 4(28):10-23 (In Russ.).] DOI 10.32756/0869-5490-2019-4-10-23.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Литовский И.А., Гордиенко А.В., Сотников А.В. Достаточно ли обоснованы цели, к которым мы стремимся? // Клиническая фармакология и терапия. 2019. Т. 4, № 28. С. 10-23. DOI 10.32756/0869-5490-2019-4-10-23.</mixed-citation><mixed-citation xml:lang="en">Yezhov M.V. [et al.] Narusheniya lipidnogo obmena. Klinicheskie rekomendatsii 2023 [Disorders of lipid metabolism. Clinical guidelines 2023]. Russian Journal of Cardiology [Rossiyskiy kardiologicheskiy zhurnal. 2023; 28 (5): 250-297 (In Russ.).] doi 10.15829/1560-4071-2023-547</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Litovsky I.A., Gordienko A.V., Sotnikov A.V. Are the goals we strive for sufficiently justified?// Clinical pharmacology and therapy. 2019. V. 4(28). P. 10-23. DOI 10.32756/0869-5490-2019-4-10-23.</mixed-citation><mixed-citation xml:lang="en">Oynotkinova O.Sh., Nikonov E.L., Kryukov E.V. Evolyutsiya dislipidemii: ot etiologicheskikh mekhanizmov k novym mishenyam personalizirovannoy profilakticheskoy nutritsevticheskoy terapii krasnym drozhzhevym risom [Evolution of dyslipidemia: from etiological mechanisms to new targets for personalized preventive nutraceutical therapy with red yeast rice]. Kardiovaskulyarnaya terapiya i profilaktika [Cardiovascular therapy and prevention. 2019; 6(18): 88-98 (In Russ.).] doi.org/10.15829/1728-8800-2019-6-88-98.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Нарушения липидного обмена. Клинические рекомендации 2023 / М.В. Ежов [и др.] // Российский кардиологический журнал. 2023. Т. 28, № 5. С. 250-297. doi 10.15829/1560-4071-2023-547</mixed-citation><mixed-citation xml:lang="en">Averkov O.V. [et al.]. Ostryy infarkt miokarda s podemom segmenta ST elektrokardiogrammy. Klinicheskie rekomendatsii 2020 [Acute myocardial infarction with ST segment elevation of the electrocardiogram. Clinical guidelines 2020]. Rossiyskiy kardiologicheskiy zhurnal [Russian Journal of Cardiology. 2020; 11: 251-310 (In Russ.).] doi:10.15829/1560-4071-2020-4103.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Disorders of lipid metabolism. Clinical guidelines 2023 / M.V. Yezhov [et al.] //Russian Journal of Cardiology. 2023. V. 28(5). P. 250-297. doi 10.15829/1560-4071-2023-547</mixed-citation><mixed-citation xml:lang="en">Otto K.M. Klinicheskaya ekhokardiografiya: prakticheskoe rukovodstvo [Clinical echocardiography: a practical guide]. Edited by Galagudzi M.M., Domnitskaya T.M., Zelenikina M.M., Kulagina T.Yu., Nikiforov V.S., Sandrikov V.A. M.: Logosphere, 2019. 1352 p. (In Russ.).] ISBN 9785-98657-064-8.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ойноткинова О.Ш., Никонов Е.Л., Крюков Е.В. Эволюция дислипидемии: от этиологических механизмов к новым мишеням персонализированной профилактической нутрицевтической терапии красным дрожжевым рисом // Кардиоваскулярная терапия и профилактика. 2019. Т. 6, № 18. С. 88-98. doi.org/10.15829/1728-8800-2019-6-88-98.</mixed-citation><mixed-citation xml:lang="en">Gordienko A.V. [et al.]. Faktory riska razvitiya ostrogo povrezhdeniya pochek pri infarkte miokarda u muzhchin molodogo i srednego vozrasta, stradayushchikh podagroy [Risk factors for the development of acute kidney injury during myocardial infarction in young and middle-aged men suffering from gout]. Mediko-farmatsevtich- eskiy zhurnal Puls [Medical and pharmaceutical journal Pulse. 2022; 24 (9):29-36 (In Russ.).] DOI 10.26787/nydha-2686-6838-2022-24-9-29-36.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Oinotkinova O.Sh., Nikonov E.L., Kryukov E.V. Evolution of dyslipidemia: from etiological mechanisms to new targets for personalized preventive nutraceutical therapy with red yeast rice // Cardiovascular therapy and prevention. 2019. V. 6(18). P. 88-98. doi.org/10.15829/1728-8800-2019-6-88-98.</mixed-citation><mixed-citation xml:lang="en">Galderisi M. [et al.]. 2016–2018 EACVI Scientific Documents Committee. Standardization of adult transthoracic echocardiography reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations: an expert consensus document of the European Association of Cardiovascular I. Eur Heart J Cardiovasc Imaging. 2017; 18(12):1301- 1310. doi: 10.1093/ehjci/jex244.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Острый инфаркт миокарда с подъемом сегмента ST электрокардиограммы. Клинические рекомендации 2020 / О.В. Аверков [и др.] // Российский кардиологический журнал. 2020. № 11. С. 251-310. doi:10.15829/1560-4071-2020-4103.</mixed-citation><mixed-citation xml:lang="en">Diaconu R. [et al.] Apolipoprotein E4 Is Associated with Right Ventricular Dysfunction in Dilated Cardiomyopathy-An Animal and In-Human Comparative Study. Int J Mol Sci. 2021; 22(18): 9688. URL: https://www.mdpi.com/1422-0067/22/18/9688 (Reference date: 07.06.2023). doi: 10.3390/ijms22189688.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Acute myocardial infarction with ST segment elevation of the electrocardiogram. Clinical guidelines 2020 / O.V. Averkov [et al.] // Russian Journal of Cardiology. 2020. V. 11. P. 251-310. doi:10.15829/1560-4071-2020-4103.</mixed-citation><mixed-citation xml:lang="en">Boratkó A., Csortos C. TIMAP, the versatile protein phosphatase 1 regulator in endothelial cells //IUBMB Life. 2017; 69(12): 918-928. doi: 10.1002/ ub.1695.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Отто К.М. Клиническая эхокардиография: практическое руководство / К.М. Отто; пер. с англ.; под ред. М.М. Галагудзы, Т.М. Домницкой, М.М. Зеленикина, Т.Ю. Кулагиной, В.С. Никифорова, В.А. Сандрикова. М.: Логосфера, 2019. 1352 с. ISBN 978-5-98657-064-8.</mixed-citation><mixed-citation xml:lang="en">Gorelova A., Berman M., Al Ghouleh I. Endothelial-to-Mesenchymal Transition in Pulmonary Arterial Hypertension. Antioxid Redox Signal. 2021. Ryter S.W., Bhatia D., Choi M.E. Autophagy: A Lysosome-Dependent Process with Implications in Cellular Redox Homeostasis and Human Disease. Antioxid Redox Signal. 2019 Jan 1;30(1):138-159. doi: 10.1089/ars.2018.7518. Epub 2018 Mar 28. PMID: 29463101; PMCID: PMC6251060. 34(12). P. 891-914. doi: 10.1089/ars.2020.8169.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Otto K.M. Clinical echocardiography: a practical guide / K.M. Otto; lane from English; edited by MM. Galagudzi, T.M. Domnitskaya, M.M. Zelenikina, T.Yu. Kulagina, V.S. Nikiforov, V.A. Sandrikov. M.: Logosphere, 2019. 1352 p. ISBN 978-5-98657-064-8.</mixed-citation><mixed-citation xml:lang="en">Virani S.S. [et al.]. Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. Circu-lation. 2021; 143(8): 254-743. doi: 10.1161/CIR.0000000000000950.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Факторы риска развития острого повреждения почек при инфаркте миокарда у мужчин молодого и среднего возраста, страдающих подагрой / А. В. Гордиенко [и др.] // Медико-фармацевтический журнал Пульс. 2022. Т. 24, № 9. С. 29-36. – DOI 10.26787/nydha-2686-6838-2022-24-9-29-36.</mixed-citation><mixed-citation xml:lang="en">Ye W. [et al.]. Heart-lung crosstalk in pulmonary arterial hypertension following myocardial infarction (Review). Int J Mol Med. 2020; 46(3): 913-924. doi: 10.3892/ijmm.2020.4650.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Risk factors for the development of acute kidney injury during myocardial infarction in young and middle-aged men suffering from gout / A. V. Gordienko [et al.] //Medical and pharmaceutical journal Pulse. 2022. V. 24(9). P. 29-36. – DOI 10.26787/nydha-2686-6838-2022-24-9-29-36.</mixed-citation><mixed-citation xml:lang="en">Johnson J.L. Elucidating the contributory role of microRNA to cardiovascular diseases (a review). Vascul. Pharmacol. 2019; 114:31-48. doi: 10.1016/j.vph.2018.10.010.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">–2018 EACVI Scientific Documents Committee. Standardization of adult transthoracic echocardiography reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations: an expert consensus document of the European Association of Cardiovascular I / M. Galderisi [et al.] // Eur Heart J Cardiovasc Imaging. 2017. V. 18(12). Р. 1301-1310. doi: 10.1093/ehjci/jex244.</mixed-citation><mixed-citation xml:lang="en">Kitabatake A., Iuone M., Asao M. Noninvasive evaluation of pulmonary hypertension by a pulsed Doppler technique. Circulation. 1983; 68(2):302-309.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Apolipoprotein E4 Is Associated with Right Ventricular Dysfunction in Dilated Cardiomyopathy-An Animal and In-Human Comparative Study / R. Diaconu [et al.] // Int J Mol Sci. 2021. V. 22(18). 9688. URL: https://www.mdpi.com/1422-0067/22/18/9688 (дата обращения: 07.06.2023). Текст: электронный. doi: 10.3390/ijms22189688.</mixed-citation><mixed-citation xml:lang="en">LDLR dysfunction induces LDL accumulation and promotes pulmonary fibrosis / X. Shi [et al.] // Clin Transl Med. 2022. V. 12(1). е711. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792399/ (дата обращения: 07.06.2023). Текст: электронный. doi: 10.1002 / ctm2.711.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Boratkó A., Csortos C. TIMAP, the versatile protein phosphatase 1 regulator in endothelial cells //IUBMB Life. 2017. V. 69(12). P. 918-928. doi: 10.1002 / iub.1695.</mixed-citation><mixed-citation xml:lang="en">Çetin M. [et al.]. Left atrial volume index and pulmonary arterial pressure predicted MACE among patients with STEMI during 8-year follow-up: experience from a tertiary center. Herz. 2021. V. 46(4). P. 367-374. doi: 10.1007/s00059020-04966-4.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Gorelova A., Berman M., Al Ghouleh I. Endothelial-to-Mesenchymal Transition in Pulmonary Arterial Hypertension // Antioxid Redox Signal. 2021. Ryter S.W., Bhatia D., Choi M.E. Autophagy: A Lysosome-Dependent Process with Implications in Cellular Redox Homeostasis and Human Disease. Antioxid Redox Signal. 2019 Jan 1;30(1):138-159. doi: 10.1089/ars.2018.7518. Epub 2018 Mar 28. PMID: 29463101; PMCID: PMC6251060. 34(12). P. 891-914. doi: 10.1089/ars.2020.8169.</mixed-citation><mixed-citation xml:lang="en">Brittain E.L. [et al.]. Mechanistic Phase II Clinical Trial of Metformin in Pulmonary Arterial Hypertension. J Am Heart Assoc. 2020; 9(22): e018349. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763730/ (Date of reference 03.07.2023). doi: 10.1161/JAHA.120.018349.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association / S.S. Virani [et al.] // Circulation. 2021. V. 143(8). P. 254-743. doi: 10.1161 / CIR.0000000000000950.</mixed-citation><mixed-citation xml:lang="en">Sharma S. [et al.] Role of oxidized lipids in pulmonary arterial hypertension. Pulm Circ. 2016; 6(3): 261-273. doi: 10.1086/687293.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Heart and lung crosstalk in pulmonary arterial hypertension following myocardial infarction (Review) / W. Ye [et al.] // Int J Mol Med. 2020. V. 46(3). P. 913-924. doi: 10.3892/ijmm.2020.4650.</mixed-citation><mixed-citation xml:lang="en">Ryter S.W., Bhatia D., Choi M.E. Autophagy: A Lysosome-Dependent Process with Implications in Cellular Redox Homeostasis and Human Disease. Antioxid Redox Signal. 2019; 30(1): 138-159. doi: 10.1089/ars.2018.7518.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Johnson J.L. Elucidating the contributory role of microRNA to cardiovascular diseases (a review) // Vascul. Pharmacol. 2019. V. 114. P. 3148. doi: 10.1016/j.vph.2018.10.010.</mixed-citation><mixed-citation xml:lang="en">Vuorio A., Lassila R., Kovanen P.T. Hypercholesterolemia and COVID-19: Statins for Lowering the Risk of Venous Thromboembolism //Frontiers in cardiovascular medicine. 2021. V. 8. 711923. URL: https://www.frontiersin.org/articles/10.3389/fcvm.2021.711923/full. (Date of reference: 08.06.2023). doi: 10.3389/fcvm.2021.711923.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Kitabatake A., Iuone M., Asao M. Noninvasive evaluation of pulmonary hypertension by a pulsed Doppler technique // Circulation. 1983. V. 68(2). P. 302-309.</mixed-citation><mixed-citation xml:lang="en">Xu J., Chen G., Yang Y. Exosomes: A Rising Star in Falling Hearts //Front. Physiol. 2017; 8: 494. doi: 10.3389/fphys.2017.00494.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">LDLR dysfunction induces LDL accumulation and promotes pulmonary fibrosis / X. Shi [et al.] // Clin Transl Med. 2022. V. 12(1). е711. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792399/ (дата обращения: 07.06.2023). Текст: электронный. doi: 10.1002/ctm2.711.</mixed-citation><mixed-citation xml:lang="en">LDLR dysfunction induces LDL accumulation and promotes pulmonary fibrosis / X. Shi [et al.] // Clin Transl Med. 2022. V. 12(1). е711. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792399/ (дата обращения: 07.06.2023). Текст: электронный. doi: 10.1002/ctm2.711.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Left atrial volume index and pulmonary arterial pressure predicted MACE among patients with STEMI during 8-year follow-up: experience from a tertiary center / M. Çetin [et al.] //Herz. 2021. V. 46(4). P. 367-374. doi: 10.1007/s00059020-04966-4.</mixed-citation><mixed-citation xml:lang="en">Left atrial volume index and pulmonary arterial pressure predicted MACE among patients with STEMI during 8-year follow-up: experience from a tertiary center / M. Çetin [et al.] //Herz. 2021. V. 46(4). P. 367-374. doi: 10.1007/s00059020-04966-4.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Mechanistic Phase II Clinical Trial of Metformin in Pulmonary Arterial Hypertension / E.L. Brittain [et al.] // J Am Heart Assoc. 2020. V. 9(22). Р. e018349. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763730/ (дата обращения: 03.07.2023). Текст: электронный. doi: 10.1161/ JAHA.120.018349.</mixed-citation><mixed-citation xml:lang="en">Mechanistic Phase II Clinical Trial of Metformin in Pulmonary Arterial Hypertension / E.L. Brittain [et al.] // J Am Heart Assoc. 2020. V. 9(22). Р. e018349. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763730/ (дата обращения: 03.07.2023). Текст: электронный. doi: 10.1161/ JAHA.120.018349.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Role of oxidized lipids in pulmonary arterial hypertension / S. Sharma [et al.] // Pulm Circ. 2016. V. 6(3). P. 261-273. doi: 10.1086/687293.</mixed-citation><mixed-citation xml:lang="en">Role of oxidized lipids in pulmonary arterial hypertension / S. Sharma [et al.] // Pulm Circ. 2016. V. 6(3). P. 261-273. doi: 10.1086/687293.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Ryter S.W., Bhatia D., Choi M.E. Autophagy: A Lysosome-Dependent Process with Implications in Cellular Redox Homeostasis and Human Disease // Antioxid Redox Signal. 2019. V. 30(1). P. 138-159. doi: 10.1089/ars.2018.7518.</mixed-citation><mixed-citation xml:lang="en">Ryter S.W., Bhatia D., Choi M.E. Autophagy: A Lysosome-Dependent Process with Implications in Cellular Redox Homeostasis and Human Disease // Antioxid Redox Signal. 2019. V. 30(1). P. 138-159. doi: 10.1089/ars.2018.7518.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Vuorio A., Lassila R., Kovanen P.T. Hypercholesterolemia and COVID-19: Statins for Lowering the Risk of Venous Thromboembolism // Frontiers in cardiovascular medicine. 2021. V. 8. 711923. URL: https://www.frontiersin.org/articles/10.3389/fcvm.2021.711923/full. (дата обращения: 08.06.2023). Текст: электронный. doi: 10.3389/fcvm.2021.711923.</mixed-citation><mixed-citation xml:lang="en">Vuorio A., Lassila R., Kovanen P.T. Hypercholesterolemia and COVID-19: Statins for Lowering the Risk of Venous Thromboembolism // Frontiers in cardiovascular medicine. 2021. V. 8. 711923. URL: https://www.frontiersin.org/articles/10.3389/fcvm.2021.711923/full. (дата обращения: 08.06.2023). Текст: электронный. doi: 10.3389/fcvm.2021.711923.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Xu J., Chen G., Yang Y. Exosomes: A Rising Star in Falling Hearts // Front. Physiol. 2017. V. 8. P. 494. doi: 10.3389/fphys.2017.00494.</mixed-citation><mixed-citation xml:lang="en">Xu J., Chen G., Yang Y. Exosomes: A Rising Star in Falling Hearts // Front. Physiol. 2017. V. 8. P. 494. doi: 10.3389/fphys.2017.00494.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
